Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients

por Sanoyan, Dilara Akhoundova, Seipel, Katja, Bacher, Ulrike, Kronig, Marie-Noelle, Porret, Naomi, Wiedemann, Gertrud, Daskalakis, Michael, Pabst, Thomas
Publicado 2023